Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

The risk of lymphoma in patients with psoriasis.

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB.

J Invest Dermatol. 2006 Oct;126(10):2194-201. Epub 2006 Jun 1.

2.

Relative versus absolute risk of comorbidities in patients with psoriasis.

Saleem MD, Kesty C, Feldman SR.

J Am Acad Dermatol. 2017 Mar;76(3):531-537. doi: 10.1016/j.jaad.2016.11.037. Epub 2016 Dec 13. Review.

PMID:
27986396
3.

Primary cutaneous T-cell lymphoma occurring after organ transplantation.

Ravat FE, Spittle MF, Russell-Jones R.

J Am Acad Dermatol. 2006 Apr;54(4):668-75. Review.

PMID:
16546591
4.
5.

Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).

Whittaker S.

Semin Oncol. 2006 Feb;33(1 Suppl 3):S3-6. Review.

PMID:
16516668
6.

Management of refractory early-stage cutaneous T-cell lymphoma.

Huber MA, Staib G, Pehamberger H, Scharffetter-Kochanek K.

Am J Clin Dermatol. 2006;7(3):155-69. Review.

PMID:
16734503
7.

[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].

Beani JC, Jeanmougin M.

Ann Dermatol Venereol. 2010 Jan;137(1):21-31. doi: 10.1016/j.annder.2009.12.004. Epub 2009 Dec 29. Review. French.

PMID:
20110064
8.

Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.

Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le MaƮtre M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.

J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:22-31. doi: 10.1111/j.1468-3083.2012.04520.x. Review.

PMID:
22512677

Supplemental Content

Support Center